Kiora Pharmaceuticals (KPRX) Assets (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Assets came in at $21.2 million in Q1 2026, down 37.6% YoY from $34.0 million in Q1 2025, and down 12.48% on a QoQ basis from $24.3 million in Q4 2025.
Kiora Pharmaceuticals (KPRX) Assets (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 13 years of Assets data on file, last reported at $21.2 million in Q1 2026.
- Quarterly Assets fell 37.6% year-over-year to $21.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.2 million (down 37.6% YoY) and the FY2025 annual result came in at $24.3 million, down 33.52% from the prior year.
- Assets retreated to $21.2 million in Q1 2026, from $24.3 million in the prior quarter.
- In the past five years, Assets ranged from a high of $42.4 million in Q1 2024 to a low of $13.7 million in Q4 2023.
- A 5-year average of $25.6 million and a median of $21.2 million in 2026 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets jumped 166.08% — and 2026, when it sank 37.6%.
- Tracing KPRX's Assets over 5 years: stood at $18.7 million in 2022, then fell by 26.59% to $13.7 million in 2023, then soared by 166.08% to $36.5 million in 2024, then sank by 33.52% to $24.3 million in 2025, then slipped by 12.48% to $21.2 million in 2026.
- The last three Assets figures came in at $21.2 million (Q1 2026), $24.3 million (Q4 2025), and $29.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - | 23.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.78 Mn |
| Mar 31, 2026 | 21.23 Mn |
| Dec 31, 2025 | 24.25 Mn |
| Sep 30, 2025 | 29.86 Mn |
| Jun 30, 2025 | 31.95 Mn |
| Mar 31, 2025 | 34.02 Mn |
| Dec 31, 2024 | 36.48 Mn |
| Sep 30, 2024 | 38.51 Mn |
| Jun 30, 2024 | 40.81 Mn |
| Mar 31, 2024 | 42.44 Mn |
| Dec 31, 2023 | 13.71 Mn |
| Sep 30, 2023 | 15.90 Mn |
| Jun 30, 2023 | 19.88 Mn |
| Mar 31, 2023 | 16.53 Mn |
| Dec 31, 2022 | 18.68 Mn |
| Sep 30, 2022 | 17.66 Mn |
| Jun 30, 2022 | 15.46 Mn |
| Mar 31, 2022 | 17.64 Mn |
| Dec 31, 2021 | 20.13 Mn |
| Sep 30, 2021 | 25.49 Mn |